Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "avtor" (Andraž Dovnik) .

1 - 9 / 9
Na začetekNa prejšnjo stran1Na naslednjo stranNa konec
1.
Diagnostic performance of p16/Ki-67 dual immunostaining at different number of positive cells in cervical smears in women referred for colposcopy
Uršula Salobir Gajšek, Andraž Dovnik, Iztok Takač, Urška Ivanuš, Tine Jerman, Simona Šramek Zatler, Alenka Repše-Fokter, 2021, izvirni znanstveni članek

Povzetek: . The aim of the study was to evaluate the diagnostic accuracy of p16/Ki-67 dual immunostaining (p16/ Ki-67 DS) in cervical cytology and the number of positive p16/Ki-67 cells to diagnose high grade cervical intraepithelial neoplasia (CIN2+) in colposcopy population. Subjects and methods. We performed an analysis on a subset cohort of 174 women enrolled within a large-scale randomised controlled human papillomavirus (HPV) self-sampling project organised as part of the population-based Cervical Cancer Screening Programme ZORA in Slovenia. This subset cohort of patients was invited to the colposcopy clinic, underwent p16/Ki-67 DS cervical cytology and had the number of p16/Ki-67 positive cells determined. Results. Among analysed women, 42/174 (24.1%) had histologically confirmed CIN2+. The risk for CIN2+ was increasing with the number of positive cells (p < 0.001). The sensitivity of p16/Ki-67 DS for detection of CIN2+ was 88.1%, specificity was 65.2%, positive predictive value was 44.6% and negative predictive value was 94.5%. Conclusions. Dual p16/Ki-67 immunostaining for the detection of CIN2+ has shown high sensitivity and high negative predictive value in our study, which is comparable to available published data. The number of p16/Ki-67 positive cells was significantly associated with the probability of CIN2+ detection. We observed a statistically significant and clinically relevant increase in specificity if the cut-off for a positive test was shifted from one cell to three cells.
Ključne besede: cervical cytology, high-grade dysplasia, p16/Ki-67 immunostaining
Objavljeno v DiRROS: 22.07.2024; Ogledov: 123; Prenosov: 48
.pdf Celotno besedilo (441,03 KB)

2.
Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage
Andraž Dovnik, Bojana Crnobrnja, Branka Žegura Andrić, Iztok Takač, Maja Pakiž, 2017, izvirni znanstveni članek

Povzetek: Background. The aim of the study was to compare the frequency of positive peritoneal washings in endometrial cancer patients after either hysteroscopy (HSC) or dilatation and curettage (D&C). Patients and methods. We performed a retrospective analysis of 227 patients who underwent either HSC (N = 144) or D&C (N = 83) and were diagnosed with endometrial carcinoma at the University Medical Centre Maribor between January 2008 and December 2014. The incidence of positive peritoneal cytology was evaluated in each group. Results. There was no overall difference in the incidence of positive peritoneal washings after HSC or D&C (HSC = 13.2%; D&C = 12.0%; p = 0.803). However, a detailed analysis of stage I disease revealed significantly higher rates of positive peritoneal washings in the HSC group (HSC = 12.8%; D&C = 3.4%; p = 0.046). Among these patients, there was no difference between both groups considering histologic type (chi-square = 0.059; p = 0.807), tumour differentiation (chi-square = 3.709; p = 0.156), the time between diagnosis and operation (t = 0.930; p = 0.357), and myometrial invasion (chi-square = 5.073; p = 0.079). Conclusions. Although the diagnostic procedure did not influence the overall incidence of positive peritoneal washings, HSC was associated with a significantly higher rate of positive peritoneal cytology in stage I endometrial carcinoma compared to D&C.
Objavljeno v DiRROS: 03.06.2024; Ogledov: 267; Prenosov: 140
.pdf Celotno besedilo (440,74 KB)
Gradivo ima več datotek! Več...

3.
4.
5.
6.
Prikaz primera : HPV negativni rak materničnega vratu
Andraž Dovnik, Maja Pakiž, Mario Poljak, 2015, objavljeni povzetek strokovnega prispevka na konferenci

Ključne besede: maternični vrat, rak (medicina), humani papilomavirus
Objavljeno v DiRROS: 09.04.2020; Ogledov: 1929; Prenosov: 539
.pdf Celotno besedilo (59,65 KB)

7.
Nove smernice za zdravljenje predrakavih sprememb materničnega vratu
Iztok Takač, Špela Smrkolj, Urška Ivanuš, Darja Arko, Andraž Dovnik, 2015, objavljeni povzetek znanstvenega prispevka na konferenci (vabljeno predavanje)

Ključne besede: maternični vrat, predrakave spremembe, zdravljenje, smernice
Objavljeno v DiRROS: 09.04.2020; Ogledov: 1921; Prenosov: 556
.pdf Celotno besedilo (51,35 KB)

8.
9.
Smernice za obravnavo bolnic z rakom materničnega vratu v Sloveniji - povzetek
Iztok Takač, Andraž Dovnik, 2012, strokovni članek

Objavljeno v DiRROS: 31.08.2018; Ogledov: 2770; Prenosov: 769
.pdf Celotno besedilo (186,75 KB)

Iskanje izvedeno v 1.1 sek.
Na vrh